盈利预期调整
Search documents
ChampionX (CHX) Q1 Earnings Surpass Estimates
ZACKS· 2025-04-29 22:50
Group 1: Earnings Performance - ChampionX reported quarterly earnings of $0.50 per share, exceeding the Zacks Consensus Estimate of $0.41 per share, representing an earnings surprise of 21.95% [1] - The company has surpassed consensus EPS estimates three times over the last four quarters [2] - The revenues for the quarter ended March 2025 were $864.46 million, missing the Zacks Consensus Estimate by 0.52%, and down from $922.14 million year-over-year [2] Group 2: Stock Performance and Outlook - ChampionX shares have declined approximately 9.1% since the beginning of the year, compared to a 6% decline in the S&P 500 [3] - The company's earnings outlook is crucial for assessing future stock performance, with current consensus EPS estimates at $0.43 for the coming quarter and $1.74 for the current fiscal year [4][7] - The Zacks Rank for ChampionX is currently 2 (Buy), indicating expectations for the stock to outperform the market in the near future [6] Group 3: Industry Context - The Engineering - R and D Services industry, to which ChampionX belongs, is currently ranked in the top 14% of over 250 Zacks industries, suggesting a favorable industry outlook [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]
Rogers Corp. (ROG) Surpasses Q1 Earnings and Revenue Estimates
ZACKS· 2025-04-29 22:50
Rogers Corp. (ROG) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.58 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 12.50%. A quarter ago, it was expected that this specialty materials company would post earnings of $0.45 per share when it actually produced earnings of $0.46, delivering a surprise of 2.22%.Over the last four quarter ...
Frontier Communications (FYBR) Reports Q1 Loss, Tops Revenue Estimates
ZACKS· 2025-04-29 22:45
Financial Performance - Frontier Communications reported a quarterly loss of $0.26 per share, better than the Zacks Consensus Estimate of a loss of $0.33, compared to break-even earnings per share a year ago, representing an earnings surprise of 21.21% [1] - The company posted revenues of $1.51 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.34%, and showing an increase from $1.46 billion year-over-year [2] Stock Performance - Frontier Communications shares have increased approximately 4.5% since the beginning of the year, contrasting with the S&P 500's decline of 6% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.34 on revenues of $1.52 billion, and for the current fiscal year, it is -$1.34 on revenues of $6.06 billion [7] - The estimate revisions trend for Frontier Communications is currently unfavorable, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Communication - Network Software industry, to which Frontier Communications belongs, is currently ranked in the bottom 13% of over 250 Zacks industries, suggesting potential challenges ahead [8]
Sonoco (SON) Q1 Earnings and Revenues Lag Estimates
ZACKS· 2025-04-29 22:45
Financial Performance - Sonoco reported quarterly earnings of $1.38 per share, missing the Zacks Consensus Estimate of $1.39 per share, but showing an increase from $1.12 per share a year ago, representing an earnings surprise of -0.72% [1] - The company posted revenues of $1.71 billion for the quarter ended March 2025, missing the Zacks Consensus Estimate by 18.89%, compared to year-ago revenues of $1.64 billion [2] - Over the last four quarters, Sonoco has surpassed consensus EPS estimates two times, but has not been able to beat consensus revenue estimates [2] Stock Performance - Sonoco shares have lost about 4.9% since the beginning of the year, while the S&P 500 has declined by 6% [3] - The current status of estimate revisions translates into a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the coming quarter is $1.52 on revenues of $1.94 billion, and for the current fiscal year, it is $5.94 on revenues of $7.99 billion [7] - The outlook for the Containers - Paper and Packaging industry is currently in the bottom 17% of the Zacks industries, which may materially impact Sonoco's stock performance [8]
Unum (UNM) Q1 Earnings and Revenues Lag Estimates
ZACKS· 2025-04-29 22:40
Group 1: Earnings Performance - Unum reported quarterly earnings of $2.04 per share, missing the Zacks Consensus Estimate of $2.19 per share, and down from $2.12 per share a year ago, representing an earnings surprise of -6.85% [1] - The company posted revenues of $3.3 billion for the quarter, missing the Zacks Consensus Estimate by 1.05%, compared to $3.2 billion in the same quarter last year [2] - Over the last four quarters, Unum has surpassed consensus EPS estimates two times and topped consensus revenue estimates just once [2] Group 2: Stock Performance and Outlook - Unum shares have increased by approximately 8.2% since the beginning of the year, contrasting with a -6% decline in the S&P 500 [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to those expectations [4] - The current consensus EPS estimate for the coming quarter is $2.26 on revenues of $3.35 billion, and for the current fiscal year, it is $9 on revenues of $13.35 billion [7] Group 3: Industry Context - The Insurance - Accident and Health industry, to which Unum belongs, is currently in the top 34% of over 250 Zacks industries, indicating a favorable industry outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Unum's stock performance [5][6]
Werner Enterprises (WERN) Reports Q1 Loss, Misses Revenue Estimates
ZACKS· 2025-04-29 22:40
Company Performance - Werner Enterprises reported a quarterly loss of $0.12 per share, matching the Zacks Consensus Estimate, and down from earnings of $0.14 per share a year ago, indicating an earnings surprise of -200% [1] - The company posted revenues of $712.11 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 4.65% and down from $769.08 million year-over-year [2] - Over the last four quarters, Werner has not surpassed consensus EPS or revenue estimates [2] Stock Outlook - Werner shares have declined approximately 21.9% since the beginning of the year, compared to a -6% decline in the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is $0.27 on revenues of $779.05 million, and for the current fiscal year, it is $1.11 on revenues of $3.13 billion [7] Industry Context - The Transportation - Truck industry, to which Werner belongs, is currently in the bottom 5% of over 250 Zacks industries, indicating a challenging environment [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Werner's stock performance [5][6]
Huron Consulting (HURN) Q1 Earnings and Revenues Top Estimates
ZACKS· 2025-04-29 22:35
Core Insights - Huron Consulting (HURN) reported quarterly earnings of $1.68 per share, exceeding the Zacks Consensus Estimate of $1.16 per share, and up from $1.23 per share a year ago, representing an earnings surprise of 44.83% [1] - The company achieved revenues of $395.69 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 1.79% and increasing from $355.96 million year-over-year [2] - Huron Consulting has consistently outperformed consensus EPS estimates over the last four quarters [2] Earnings Performance - The earnings surprise for the previous quarter was 25%, with actual earnings of $1.90 per share compared to an expected $1.52 per share [1] - The current consensus EPS estimate for the upcoming quarter is $1.84, with projected revenues of $402.37 million, and for the current fiscal year, the estimate is $7.15 on $1.62 billion in revenues [7] Stock Performance - Huron Consulting shares have increased by approximately 8.9% since the beginning of the year, contrasting with a -6% decline in the S&P 500 [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating expectations of outperforming the market in the near future [6] Industry Outlook - The Consulting Services industry is ranked in the top 10% of over 250 Zacks industries, suggesting a favorable outlook for stocks within this sector [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]
BridgeBio Pharma (BBIO) Reports Q1 Loss, Tops Revenue Estimates
ZACKS· 2025-04-29 22:35
Financial Performance - BridgeBio Pharma reported a quarterly loss of $0.88 per share, which was better than the Zacks Consensus Estimate of a loss of $1, representing an earnings surprise of 12% [1] - The company posted revenues of $116.63 million for the quarter ended March 2025, exceeding the Zacks Consensus Estimate by 86.76%, although this is a decline from year-ago revenues of $211.12 million [2] - Over the last four quarters, BridgeBio Pharma has surpassed consensus EPS estimates three times and topped consensus revenue estimates two times [2] Stock Performance - Since the beginning of the year, BridgeBio Pharma shares have increased by approximately 30.8%, contrasting with a decline of 6% in the S&P 500 [3] - The stock's immediate price movement will largely depend on management's commentary during the earnings call [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.98 on revenues of $60.98 million, and for the current fiscal year, it is -$4.18 on revenues of $255.08 million [7] - The estimate revisions trend for BridgeBio Pharma is currently unfavorable, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Medical - Generic Drugs industry, to which BridgeBio Pharma belongs, is currently ranked in the top 29% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]
Visa (V) Surpasses Q2 Earnings and Revenue Estimates
ZACKS· 2025-04-29 22:20
Group 1: Earnings Performance - Visa reported quarterly earnings of $2.76 per share, exceeding the Zacks Consensus Estimate of $2.68 per share, and up from $2.51 per share a year ago, representing an earnings surprise of 2.99% [1] - The company posted revenues of $9.59 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.34%, compared to $8.78 billion in the same quarter last year [2] - Over the last four quarters, Visa has consistently surpassed consensus EPS estimates four times and topped revenue estimates three times [2] Group 2: Stock Performance and Outlook - Visa shares have increased approximately 6.8% since the beginning of the year, contrasting with a -6% decline in the S&P 500 [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to those expectations [4] - The current consensus EPS estimate for the upcoming quarter is $2.83 on revenues of $9.86 billion, and for the current fiscal year, it is $11.30 on revenues of $39.6 billion [7] Group 3: Industry Context - The Financial Transaction Services industry, to which Visa belongs, is currently ranked in the top 28% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Visa's stock performance [5][6]
Ecolab (ECL) Meets Q1 Earnings Estimates
ZACKS· 2025-04-29 14:10
Company Performance - Ecolab reported quarterly earnings of $1.50 per share, matching the Zacks Consensus Estimate, and showing an increase from $1.34 per share a year ago [1] - The company posted revenues of $3.7 billion for the quarter ended March 2025, slightly missing the Zacks Consensus Estimate by 0.07%, and down from $3.75 billion year-over-year [2] - Over the last four quarters, Ecolab has surpassed consensus EPS estimates three times and topped revenue estimates only once [2] Stock Outlook - Ecolab shares have increased approximately 2% since the beginning of the year, contrasting with a -6% decline in the S&P 500 [3] - The company's earnings outlook is crucial for investors, with current consensus EPS estimates at $1.90 for the coming quarter and $7.51 for the current fiscal year [7] - The current Zacks Rank for Ecolab is 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Context - The Chemical - Specialty industry, to which Ecolab belongs, is currently ranked in the bottom 40% of over 250 Zacks industries, which may impact stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that industry outlook can significantly affect stock performance [5][8]